Molbio Diagnostics
Ticker > Company >

Molbio Diagnostics share price

Molbio Diagnostics Ltd.

 142   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year28.42%
3 YearNA
5 YearNA

Profit Growth

1 Year25.84%
3 YearNA
5 YearNA

ROE%

1 Year15.2%
3 Year10.43%

ROCE %

1 Year20.47%
3 Year14.25%

Debt/Equity

0.0176

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has significantly decreased its debt by 49.024 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Net Sales 326.57 756.32 971.23
Total Expenditure 286.49 552.62 745.6
Operating Profit 40.09 203.69 225.64
Other Income 8.1 6.52 6.37
Interest 5.94 7.61 8.86
Depreciation 19.39 23.6 26.31
Exceptional Items 0 -27.12 -8.8
Profit Before Tax 22.86 151.89 188.04
Tax 7.31 40.78 48.22
Net Profit 15.55 111.11 139.82
Adjusted EPS (Rs.) 1.38 9.86 12.4

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 2.25 2.25 2.26
Total Reserves 736.72 847.73 987.82
Borrowings 0.99 15.12 6.14
Other N/C liabilities -4.2 -20.95 -33.92
Current liabilities 177.6 209.81 303.94
Total Liabilities 913.35 1053.97 1266.24
Assets
Net Block 189.31 175.93 214.92
Capital WIP 0 1.58 17.6
Intangible WIP 0 0 0
Investments 53.79 53.79 95.35
Loans & Advances 32.76 50.38 99.85
Other N/C Assets 26.73 48.77 11.99
Current Assets 610.76 723.52 826.53
Total Assets 913.35 1053.97 1266.24
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025
Profit from operations 151.89 188.04
Adjustment 85.62 58.76
Changes in Assets & Liabilities -157.07 66.35
Tax Paid -42.7 -64.57
Operating Cash Flow 37.74 248.58
Investing Cash Flow -31.44 -97.9
Financing Cash Flow -24.2 -17.35
Net Cash Flow -17.91 133.33

Corporate Actions

Molbio Diagnostics Share Price News

Latest updates on Molbio Diagnostics share price and stock news.

View More Blogs
Last Updated on:
Brief about Molbio Diagnostics
X